BioNTech SE
NASDAQ:BNTX

Watchlist Manager
BioNTech SE Logo
BioNTech SE
NASDAQ:BNTX
Watchlist
Price: 101.81 USD 3.09% Market Closed
Market Cap: 24.5B USD

Intrinsic Value

BNTX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one BNTX stock under the Base Case scenario is 31.76 USD. Compared to the current market price of 101.81 USD, BioNTech SE is Overvalued by 69%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BNTX Intrinsic Value
31.76 USD
Overvaluation 69%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
BioNTech SE

BNTX
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for BNTX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

BioNTech SE
NASDAQ:BNTX
DE
Biotechnology
Market Cap
24.4B USD
IPO
Oct 10, 2019
DE
Biotechnology
Market Cap
24.4B USD
IPO
Oct 10, 2019
Price
$false
EPS
€false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BNTX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about BioNTech SE
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
BioNTech SE

Current Assets 18.8B
Cash & Short-Term Investments 16.8B
Receivables 1.5B
Other Current Assets 496m
Non-Current Assets 3.7B
Long-Term Investments 1.3B
PP&E 1.2B
Intangibles 1.2B
Other Non-Current Assets 117.8m
Efficiency

Free Cash Flow Analysis
BioNTech SE

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
BioNTech SE

Revenue
2.8B EUR
Cost of Revenue
-415.5m EUR
Gross Profit
2.3B EUR
Operating Expenses
-3.5B EUR
Operating Income
-1.2B EUR
Other Expenses
493.5m EUR
Net Income
-665.3m EUR
Fundamental Scores

BNTX Profitability Score
Profitability Due Diligence

BioNTech SE's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional 3-Year Average ROE
Negative Free Cash Flow
Positive Gross Profit
61/100
Profitability
Score

BioNTech SE's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

BNTX Solvency Score
Solvency Due Diligence

BioNTech SE's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

BioNTech SE's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BNTX Price Targets Summary
BioNTech SE

Wall Street analysts forecast BNTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BNTX is 139.02 USD with a low forecast of 100.23 USD and a high forecast of 179.55 USD.

Lowest
Price Target
100.23 USD
2% Downside
Average
Price Target
139.02 USD
37% Upside
Highest
Price Target
179.55 USD
76% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BNTX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

BNTX News

Other Videos
What is the Intrinsic Value of one BNTX stock?

The intrinsic value of one BNTX stock under the Base Case scenario is 31.76 USD.

Is BNTX stock undervalued or overvalued?

Compared to the current market price of 101.81 USD, BioNTech SE is Overvalued by 69%.

Back to Top